Health News

Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013

Author: Australian Business

WASHINGTON, Oct. 21, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the......

More...

More Articles...

Electrocardiography (ECG) Devices - Emerging Markets 2009-2015
Global Animal/Veterinary Vaccines Market - 2013 Report
mHealth Apps Solutions Market - Global Trends Forecast to 2018
Global Cardiac Resynchronization Therapy (CRT) Devices - Market Growth Analysis, 2009-2015
Dr. William Jennings to present VWING Vascular Needle Guide SAVE study results at 2013 CIDA
Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
ACMA Releases New Standards of Practice and Scope of Services for Health Care Delivery System Case Management and Transitions of Care Professionals
Anti-Adhesion Products - Global Strategic Business Report
Emdeon to Add Color Printing to Member Communication Capabilities
Mobile Health Solutions Market US M-Commerce 2016 Reports

Page 818 of 1906